Sideroblastic refractory anemia in a patient with systemic lupus erythematosus.
D000328:Adult; D000756:Anemia, Sideroblastic / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D004920:Erythropoiesis; D004921:Erythropoietin / Q000097:blood; D005078:Exchange Transfusion, Whole Blood; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000097:blood; D007538:Isoniazid / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008297:Male; D008533:Megakaryocytes; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000150:complications; D011736:Pyridoxine / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D004921:Erythropoietin; D005492:Folic Acid; D007501:Iron; D011736:Pyridoxine; D014805:Vitamin B 12; D007538:Isoniazid; D011241:Prednisone